Loading...
The pancreatic niche inhibits the effectiveness of sunitinib treatment of pancreatic cancer
Current treatments for pancreatic ductal adenocarcinoma (PDA) are ineffective, making this the 4(th) leading cause of cancer deaths. Sunitinib is a broad-spectrum inhibitor of tyrosine kinase receptors mostly known for its anti-angiogenic effects. We tested the therapeutic effects of sunitinib in pa...
Na minha lista:
| Udgivet i: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals LLC
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5217016/ https://ncbi.nlm.nih.gov/pubmed/27374084 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10199 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|